VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery s ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
After decades of export-focused economic policy, Mexico is looking back at its domestic market. Last year, the government ...
Nature Health, the newest journal in the Nature Portfolio, aims to bridge the ‘implementation gap’ from research to policy ...
The term ‘development’ has been central to global conversations for decades, but the way it is understood, practised, and questioned has shifted dramatically. In this Between the Lines podcast episode ...
Mechanical cues are key regulators of cardiac development, yet their role in organoid maturation remains underexplored. In a ...
Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is ...
Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is ...
Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026 Full imaging and dosimetry data from MP0712 compassionate care program ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech ...
We constantly refer to the fast rate of progress as economies expand, technology accelerates and globalisation advances. The main agents of economic growth are increased investment, new construction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results